article thumbnail

CAFC Reverses January Decision Affirming Sufficient Written Description for Negative Claim Limitation Over Judge Linn’s Dissent

IP Watchdog

Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. Earlier today, the U.S. Accord Healthcare, Inc. granting a petition for rehearing from appellant HEC Pharm Co.,

article thumbnail

Exposure Lawsuits: Trends, Challenges, Future Implications

CaseFox

From the traditional focus on environmental and occupational hazards to the exploration of new frontiers in pharmaceuticals and consumer products. Cases related to pharmaceutical drugs, consumer products, and emerging contaminants in drinking water are gaining prominence.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Companies Agree to Ulcer-Inducing Settlement Over Zantac

Practice of Law

All of these are major pharmaceutical companies with extensive histories and significant roles in the development, manufacturing, and distribution of medications – and one in particular: ranitidine. There, plaintiffs were allowed to present expert testimony on the cancer link. You might recognize it better as Zantac.

article thumbnail

Federal Rule of Evidence 702: A Useful Rule (When It's Followed)

Evidence at Trial

And when it comes to expert opinion testimony, there can be even more uncertainty. Merrell Dow Pharmaceuticals, Inc. —exclude the opinion on the ground that it is fulfilling its gatekeeping role to "ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable." Weisgram v.